Chalie Mulugeta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chalie Mulugeta has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
Abebaw Alamrew
Department of Midwifery, College of Health Science, Woldia University, Woldia City, Ethiopia
8 shared publicationsTadele Emagneneh
Department of Midwifery, College of Health Science Woldia University Woldia City Ethiopia
8 shared publications- Abebaw Alamrew
Department of Midwifery, College of Health Science Woldia University Woldia City Ethiopia
6 shared publications Getinet Kumie
Woldia University, Weldiya, Ethiopia
6 shared publications- Tadele Emagneneh
Woldia University, Weldiya, Ethiopia
5 shared publications Assefa Sisay
Woldia University, Weldiya, Ethiopia
4 shared publications
Latest Publications
- Open Access
- 7 October 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (10)
Global, Regional and National Burden of Hemolytic Disease and Other Neonatal Jaundice, 1980/90‐2021, and Projections to 2050: A Global Burden of Disease Study 2021
Background and Aims: Hemolytic disease of the fetus and newborn and other forms of neonatal jaundice remain important causes of morbidity and mortality among children under five worldwide. Despite improvements in prevention and treatment such as Rh screening, phototherapy, and exchange transfusion, the burden remains uneven across regions. This study assessed global, regional, and national trends in incidence, prevalence, mortality, Disability‐Adjusted Life Years (DALYs), Years of Life Lost (YLLs), and Years Lived with Disability (YLDs) from 1980/1990 to 2021 using Global Burden of Disease (GBD) 2021 data. Methods: Data were obtained from the GBD 2021 study via the Global Health Data Exchange. Estimates of incidence, prevalence, deaths, DALYs, YLLs, and YLDs among children under five were analyzed globally and by region. For consistency with data availability, incidence, prevalence, mortality, DALYs, and YLDs were analyzed for the period 1990–2021, while YLLs were additionally assessed for the extended period 1980–2021. Joinpoint regression analysis was used to evaluate temporal trends and estimate the average annual percentage change (AAPC) with 95% confidence intervals. Results: Globally, the incidence of hemolytic disease and neonatal jaundice among children under five declined from 31,460.13 to 24,879.37 per 100,000 population between 1990 and 2021 (AAPC = −0.84%), while prevalence increased from 218,230.47 to 288,222.33 cases (AAPC = 0.90%). Mortality decreased from 16.59 to 5.11 per 100,000 (AAPC = −3.74%), and DALY rates declined from 1504.65 to 474.68 per 100,000 (AAPC = −3.67%). YLLs decreased from 2096.02 to 459.72 per 100,000 between 1980 and 2021 (AAPC = −3.64%), whereas YLDs increased slightly from 13.04 to 14.95 per 1000 (AAPC = 0.45%). Conclusion: Over the past four decades, mortality and overall disease burden have declined substantially, reflecting improvements in neonatal care. However, increasing prevalence and YLDs indicate a continuing burden of non‐fatal complications. Marked regional disparities persist, particularly in Sub‐Saharan Africa and South Asia, highlighting the need for strengthened and equitable neonatal health services.
- 7 October 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (10)
Open AccessGlobal, Regional and National Burden of Hemolytic Disease and Other Neonatal Jaundice, 1980/90‐2021, and Projections to 2050: A Global Burden of Disease Study 2021
Background and Aims: Hemolytic disease of the fetus and newborn and other forms of neonatal jaundice remain important causes of morbidity and mortality among children under five worldwide. Despite improvements in prevention and treatment such as Rh screening, phototherapy, and exchange transfusion, the burden remains uneven across regions. This study assessed global, regional, and national trends in incidence, prevalence, mortality, Disability‐Adjusted Life Years (DALYs), Years of Life Lost (YLLs), and Years Lived with Disability (YLDs) from 1980/1990 to 2021 using Global Burden of Disease (GBD) 2021 data. Methods: Data were obtained from the GBD 2021 study via the Global Health Data Exchange. Estimates of incidence, prevalence, deaths, DALYs, YLLs, and YLDs among children under five were analyzed globally and by region. For consistency with data availability, incidence, prevalence, mortality, DALYs, and YLDs were analyzed for the period 1990–2021, while YLLs were additionally assessed for the extended period 1980–2021. Joinpoint regression analysis was used to evaluate temporal trends and estimate the average annual percentage change (AAPC) with 95% confidence intervals. Results: Globally, the incidence of hemolytic disease and neonatal jaundice among children under five declined from 31,460.13 to 24,879.37 per 100,000 population between 1990 and 2021 (AAPC = −0.84%), while prevalence increased from 218,230.47 to 288,222.33 cases (AAPC = 0.90%). Mortality decreased from 16.59 to 5.11 per 100,000 (AAPC = −3.74%), and DALY rates declined from 1504.65 to 474.68 per 100,000 (AAPC = −3.67%). YLLs decreased from 2096.02 to 459.72 per 100,000 between 1980 and 2021 (AAPC = −3.64%), whereas YLDs increased slightly from 13.04 to 14.95 per 1000 (AAPC = 0.45%). Conclusion: Over the past four decades, mortality and overall disease burden have declined substantially, reflecting improvements in neonatal care. However, increasing prevalence and YLDs indicate a continuing burden of non‐fatal complications. Marked regional disparities persist, particularly in Sub‐Saharan Africa and South Asia, highlighting the need for strengthened and equitable neonatal health services.
- Open Access
- 6 October 2026
- Published by BMJ in BMJ Global Health
- Vol. 11 (10) , e018721
5-year survival rate and determinants of decreased survival among patients with breast cancer in Africa: a systematic review and meta-analysis
Introduction: Breast cancer is the most commonly diagnosed cancer among women worldwide and a leading cause of cancer-related mortality. Survival varies across regions, with most deaths occurring in low- and middle-income countries due to limited early detection and treatment access. This study aimed to estimate the 5-year survival rate and identify determinants of decreased survival among patients with breast cancer in Africa. Methods: A systematic review of only retrospective cohort studies was conducted using PubMed, Hinari, EMBASE, Google Scholar, African Journals Online, African Index Medicus and Web of Science. The literature search was conducted for a 1-month duration (1–30 November 2024). We included all available articles without restriction on publication date to ensure a comprehensive review. Methodological quality was assessed using the Newcastle-Ottawa 2016 Critical Appraisal Checklist. Publication bias was evaluated using funnel plots and Egger’s test, and heterogeneity was assessed with the I 2 test. Data were analysed with Stata V.17. Results: 55 articles with 19 577 participants from 19 countries were included; 37 studies (4622 participants) were used to estimate pooled 5-year survival. The pooled 5-year survival rate of patients with breast cancer in Africa was 40.38% (95% CI 33.92 to 46.83%). Reduced survival was strongly associated with tumour characteristics, including tumour stage >2 (HR 3.06, 95% CI 2.02 to 4.09), negative oestrogen receptor status (HR 2.52, 95% CI 1.89 to 3.15), tumour size >5 cm (HR 1.62, 95% CI 1.48 to 1.76), positive nodal status (HR 1.64, 95% CI 1.58 to 1.70) and higher histological grade (HR 1.26, 95% CI 1.22 to 1.29). Treatment-related factors such as single-agent chemotherapy (HR 1.78, 95% CI 1.04 to 2.53) and patient-related factors, including comorbidities (HR 1.45, 95% CI 1.40 to 1.50) and illiteracy (HR 6.54, 95% CI 4.39 to 8.69), were also associated with reduced survival. Conclusion: This study reveals a critically low 5-year survival rate of 40.4% for breast cancer in Africa. Poor survival is linked to advanced tumour features, suboptimal treatment and patient-related factors, with comorbidities and illiteracy being the strongest patient-related factors. These results highlight the urgent need for integrated strategies focused on early diagnosis, public education, equitable access to multimodal therapies and systematic management of comorbidities across the continent. PROSPERO registration number: CRD420261387399.
- 6 October 2026
- Published by BMJ in BMJ Global Health
- Vol. 11 (10) , e018721
Open Access5-year survival rate and determinants of decreased survival among patients with breast cancer in Africa: a systematic review and meta-analysis
Introduction: Breast cancer is the most commonly diagnosed cancer among women worldwide and a leading cause of cancer-related mortality. Survival varies across regions, with most deaths occurring in low- and middle-income countries due to limited early detection and treatment access. This study aimed to estimate the 5-year survival rate and identify determinants of decreased survival among patients with breast cancer in Africa. Methods: A systematic review of only retrospective cohort studies was conducted using PubMed, Hinari, EMBASE, Google Scholar, African Journals Online, African Index Medicus and Web of Science. The literature search was conducted for a 1-month duration (1–30 November 2024). We included all available articles without restriction on publication date to ensure a comprehensive review. Methodological quality was assessed using the Newcastle-Ottawa 2016 Critical Appraisal Checklist. Publication bias was evaluated using funnel plots and Egger’s test, and heterogeneity was assessed with the I 2 test. Data were analysed with Stata V.17. Results: 55 articles with 19 577 participants from 19 countries were included; 37 studies (4622 participants) were used to estimate pooled 5-year survival. The pooled 5-year survival rate of patients with breast cancer in Africa was 40.38% (95% CI 33.92 to 46.83%). Reduced survival was strongly associated with tumour characteristics, including tumour stage >2 (HR 3.06, 95% CI 2.02 to 4.09), negative oestrogen receptor status (HR 2.52, 95% CI 1.89 to 3.15), tumour size >5 cm (HR 1.62, 95% CI 1.48 to 1.76), positive nodal status (HR 1.64, 95% CI 1.58 to 1.70) and higher histological grade (HR 1.26, 95% CI 1.22 to 1.29). Treatment-related factors such as single-agent chemotherapy (HR 1.78, 95% CI 1.04 to 2.53) and patient-related factors, including comorbidities (HR 1.45, 95% CI 1.40 to 1.50) and illiteracy (HR 6.54, 95% CI 4.39 to 8.69), were also associated with reduced survival. Conclusion: This study reveals a critically low 5-year survival rate of 40.4% for breast cancer in Africa. Poor survival is linked to advanced tumour features, suboptimal treatment and patient-related factors, with comorbidities and illiteracy being the strongest patient-related factors. These results highlight the urgent need for integrated strategies focused on early diagnosis, public education, equitable access to multimodal therapies and systematic management of comorbidities across the continent. PROSPERO registration number: CRD420261387399.
- Open Access
- 9 August 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (8) , e72992
Development and Validation of a Clinical Prognostic Risk Score for Stillbirth in Ethiopia: A Cohort Study Using PMA Data
Background: Stillbirth remain a major public health concern, particularly in low‐resource settings. Early identification of women at risk can significantly improve neonatal outcomes. This study aimed to Development and Validation of a Clinical Prognostic Risk Score for Stillbirth in Ethiopia: A Cohort Study Using PMA Data. Methods: A predictive model was developed using Performance Monitoring for Action (PMA) data from women. The data were exported to R version 4.4.3 for cleaning and analysis. Fifteen candidate predictors were initially considered and selected using Least Absolute Shrinkage and Selection Operator (LASSO) logistic regression with 10‐fold cross‐validation. Model performance was evaluated in terms of discrimination (area under the curve [AUC]), calibration, Brier score, and the Spiegelhalter test. Clinical usefulness was assessed using decision curve analysis (DCA). Internal validation was performed using bootstrap resampling. Finally, a simplified risk score and nomogram were developed to facilitate clinical application. Results: Predictors retained in the final model included prolonged labor, membrane rupture before 9 months, membrane rupture > 24 h during delivery, and partner encouragement for ANC. The model demonstrated excellent discrimination (AUC = 0.905) and calibration (optimism‐corrected slope = 1.005; Brier score = 0.0072; Spiegelhalter p = 1.00). The simplified risk score (range 0–10) showed strong discrimination, with high scores strongly associated with stillbirth (LR 159.7 for scores 9–10). Using a cutoff ≥ 2, the model achieved 83% sensitivity, 93% specificity, 15% PPV, and 100% NPV. Conclusion: The four‐factor prediction model, along with its simplified risk score and nomogram, accurately identifies pregnancies at high risk of stillbirth in Ethiopian women. By providing individualized risk estimates, the tool can support clinical decision‐making and help prioritize interventions for those most at risk. External validation is needed before it can be widely applied in practice.
- 9 August 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (8) , e72992
Open AccessDevelopment and Validation of a Clinical Prognostic Risk Score for Stillbirth in Ethiopia: A Cohort Study Using PMA Data
Background: Stillbirth remain a major public health concern, particularly in low‐resource settings. Early identification of women at risk can significantly improve neonatal outcomes. This study aimed to Development and Validation of a Clinical Prognostic Risk Score for Stillbirth in Ethiopia: A Cohort Study Using PMA Data. Methods: A predictive model was developed using Performance Monitoring for Action (PMA) data from women. The data were exported to R version 4.4.3 for cleaning and analysis. Fifteen candidate predictors were initially considered and selected using Least Absolute Shrinkage and Selection Operator (LASSO) logistic regression with 10‐fold cross‐validation. Model performance was evaluated in terms of discrimination (area under the curve [AUC]), calibration, Brier score, and the Spiegelhalter test. Clinical usefulness was assessed using decision curve analysis (DCA). Internal validation was performed using bootstrap resampling. Finally, a simplified risk score and nomogram were developed to facilitate clinical application. Results: Predictors retained in the final model included prolonged labor, membrane rupture before 9 months, membrane rupture > 24 h during delivery, and partner encouragement for ANC. The model demonstrated excellent discrimination (AUC = 0.905) and calibration (optimism‐corrected slope = 1.005; Brier score = 0.0072; Spiegelhalter p = 1.00). The simplified risk score (range 0–10) showed strong discrimination, with high scores strongly associated with stillbirth (LR 159.7 for scores 9–10). Using a cutoff ≥ 2, the model achieved 83% sensitivity, 93% specificity, 15% PPV, and 100% NPV. Conclusion: The four‐factor prediction model, along with its simplified risk score and nomogram, accurately identifies pregnancies at high risk of stillbirth in Ethiopian women. By providing individualized risk estimates, the tool can support clinical decision‐making and help prioritize interventions for those most at risk. External validation is needed before it can be widely applied in practice.
- Open Access
- 6 July 2026
- Published by Wiley in Nursing Open
- Vol. 13 (7) , e70680
Determinants of Recovery From Obstetric Fistula in Ethiopia: A Systematic Review and Meta‐Analysis
Aim: This study aimed to assess the prevalence of recovery from obstetric fistula and identify factors associated with recovery amongst women in Ethiopia. Design: A systematic review and meta‐analysis of retrospective cohort studies were conducted. Methods: A comprehensive search was performed in PubMed, Google Scholar, EMBASE, Cochrane Library and Hinari using relevant keywords and Boolean operators. In addition, grey literature sources such as Google Scholar, institutional repositories and reports from international organisations. Data extraction was done using Microsoft Excel, and statistical analyses were conducted in Stata version 11. The methodological quality of the studies was assessed using the Newcastle–Ottawa Scale. Publication bias was evaluated with a funnel plot and Egger's test, and heterogeneity was measured using the I‐squared statistic. Results: Ten studies including 2382 participants from four regions of Ethiopia, were analysed. The pooled prevalence of recovery from obstetric fistula was 80.42% (95% CI: 75.74–85.10). Factors significantly associated with recovery included: maternal height ≤ 150 cm (AHR: 1.30; 95% CI: 1.14–1.47; I 2 = 83.5%), antenatal care attendance (AHR: 1.30; 95% CI: 1.08–1.52; I 2 = 96.8%), institutional delivery (AHR: 1.40; 95% CI: 1.12–1.70; I 2 = 97.3%), duration of incontinence < 3 months (AHR: 1.41; 95% CI: 1.11–1.71), intact urethra (AHR: 2.27; 95% CI: 1.39–3.14; I 2 = 99.3%), vaginal delivery (AHR: 1.69; 95% CI: 1.10–2.28; I 2 = 99.1%) and fistula width ≤ 2 cm (AHR: 1.43; 95% CI: 1.05–1.81; I 2 = 97%). No Patient or Public Contribution: This study was based on previously published studies, and no direct patient or public involvement was included. Conclusion: Recovery from obstetric fistula in Ethiopia remains suboptimal. Factors significantly associated with better recovery outcomes included maternal height, antenatal care attendance, institutional delivery, mode of delivery, duration of incontinence ≤ 3 months, intact urethra and fistula width ≤ 2 cm. Targeted interventions focusing on these factors—such as increasing antenatal care uptake, promoting institutional deliveries and ensuring early management of incontinence—are essential to improve recovery outcomes for affected women. Trial Registration: PROSPERO: CRD420261422331
- 6 July 2026
- Published by Wiley in Nursing Open
- Vol. 13 (7) , e70680
Open AccessDeterminants of Recovery From Obstetric Fistula in Ethiopia: A Systematic Review and Meta‐Analysis
Aim: This study aimed to assess the prevalence of recovery from obstetric fistula and identify factors associated with recovery amongst women in Ethiopia. Design: A systematic review and meta‐analysis of retrospective cohort studies were conducted. Methods: A comprehensive search was performed in PubMed, Google Scholar, EMBASE, Cochrane Library and Hinari using relevant keywords and Boolean operators. In addition, grey literature sources such as Google Scholar, institutional repositories and reports from international organisations. Data extraction was done using Microsoft Excel, and statistical analyses were conducted in Stata version 11. The methodological quality of the studies was assessed using the Newcastle–Ottawa Scale. Publication bias was evaluated with a funnel plot and Egger's test, and heterogeneity was measured using the I‐squared statistic. Results: Ten studies including 2382 participants from four regions of Ethiopia, were analysed. The pooled prevalence of recovery from obstetric fistula was 80.42% (95% CI: 75.74–85.10). Factors significantly associated with recovery included: maternal height ≤ 150 cm (AHR: 1.30; 95% CI: 1.14–1.47; I 2 = 83.5%), antenatal care attendance (AHR: 1.30; 95% CI: 1.08–1.52; I 2 = 96.8%), institutional delivery (AHR: 1.40; 95% CI: 1.12–1.70; I 2 = 97.3%), duration of incontinence < 3 months (AHR: 1.41; 95% CI: 1.11–1.71), intact urethra (AHR: 2.27; 95% CI: 1.39–3.14; I 2 = 99.3%), vaginal delivery (AHR: 1.69; 95% CI: 1.10–2.28; I 2 = 99.1%) and fistula width ≤ 2 cm (AHR: 1.43; 95% CI: 1.05–1.81; I 2 = 97%). No Patient or Public Contribution: This study was based on previously published studies, and no direct patient or public involvement was included. Conclusion: Recovery from obstetric fistula in Ethiopia remains suboptimal. Factors significantly associated with better recovery outcomes included maternal height, antenatal care attendance, institutional delivery, mode of delivery, duration of incontinence ≤ 3 months, intact urethra and fistula width ≤ 2 cm. Targeted interventions focusing on these factors—such as increasing antenatal care uptake, promoting institutional deliveries and ensuring early management of incontinence—are essential to improve recovery outcomes for affected women. Trial Registration: PROSPERO: CRD420261422331
- Open Access
Global, regional and national burden of maternal haemorrhage (2000–2021) and projections to 2050 in 204 countries and territories
Objective To estimate the global, regional and national burden of maternal haemorrhage (2000–2021) and its 2050 projections in 204 countries and territories. Design This study systematic analysis of the burden of maternal haemorrhage sourced data from the Global Burden of Disease (GBD) 2021 study. We estimated the incidence, mortality, disability-adjusted life years (DALYs), years lived with disability (YLDs) and years of life lost (YLLs) due to maternal haemorrhage. Changes in the burden from 2000 to 2021 were computed using AAPC. To detect statistically notable changes in the trends of maternal haemorrhage metrics between 2000 and 2021, Joinpoint regression analysis using the Joinpoint Regression Programme was conducted. We also projected mortality rates, YLDs and YLLs through to 2050 using maps and trends generated by the GBD Foresight visualisation tool. Results Globally, the incidence of maternal haemorrhage among women aged 15–49 years declined from 881.98 per 100 000 reproductive aged women (95% uncertainty interval (UI) 687.01 to –1150.23) in 2000 to 714.00 (95% UI 556.97 o t908.54) in 2021, with an average annual percentage change (AAPC) of –0.91 (–1.37 to –0.49). Similar downward trends were observed for maternal deaths, DALYs, YLDs and YLLs attributable to maternal haemorrhage, with AAPCs of –3.78 (–4.39 to –3.18), –4.68 (–4.83 to –4.55), –1.21 (–1.54 to –0.89) and –4.80 (–5.10 to –4.52), respectively. Sub-Saharan Africa, particularly Western Sub-Saharan Africa, recorded the highest burden in 2021, which is almost 300 times higher than in Western Europe. Elevated rates of mortality, DALYs and YLDs were also evident in Sierra Leone, Chad, Niger, Mali, Nigeria, Burkina Faso, Central African Republic, Somalia and South Sudan in 2021 and projections for 2050. However, the high-income Asia Pacific region had the lowest incidence, DALYs and YLDs at 151.32 (109.63–203.68), 2.21 (1.72–2.86) and 0.87 (0.46–1.38) per 1 00 000 women, respectively. Australasia recorded the lowest maternal death count and YLLs attributed to maternal haemorrhage at 0.69 (0.50–0.90) and 0.56 (0.41–0.74) per 1 00 000 women, respectively. Conclusion While the global burden of maternal haemorrhage has declined over time, significant regional and national inequities persist. Even though the 2050 projections show improvement in the burden of maternal haemorrhage, there is also regional and national variation in the rate of decrease in maternal haemorrhage burden. Targeted, context-specific interventions are urgently needed to reduce maternal haemorrhage-related mortality and morbidity.
Open AccessGlobal, regional and national burden of maternal haemorrhage (2000–2021) and projections to 2050 in 204 countries and territories
Objective To estimate the global, regional and national burden of maternal haemorrhage (2000–2021) and its 2050 projections in 204 countries and territories. Design This study systematic analysis of the burden of maternal haemorrhage sourced data from the Global Burden of Disease (GBD) 2021 study. We estimated the incidence, mortality, disability-adjusted life years (DALYs), years lived with disability (YLDs) and years of life lost (YLLs) due to maternal haemorrhage. Changes in the burden from 2000 to 2021 were computed using AAPC. To detect statistically notable changes in the trends of maternal haemorrhage metrics between 2000 and 2021, Joinpoint regression analysis using the Joinpoint Regression Programme was conducted. We also projected mortality rates, YLDs and YLLs through to 2050 using maps and trends generated by the GBD Foresight visualisation tool. Results Globally, the incidence of maternal haemorrhage among women aged 15–49 years declined from 881.98 per 100 000 reproductive aged women (95% uncertainty interval (UI) 687.01 to –1150.23) in 2000 to 714.00 (95% UI 556.97 o t908.54) in 2021, with an average annual percentage change (AAPC) of –0.91 (–1.37 to –0.49). Similar downward trends were observed for maternal deaths, DALYs, YLDs and YLLs attributable to maternal haemorrhage, with AAPCs of –3.78 (–4.39 to –3.18), –4.68 (–4.83 to –4.55), –1.21 (–1.54 to –0.89) and –4.80 (–5.10 to –4.52), respectively. Sub-Saharan Africa, particularly Western Sub-Saharan Africa, recorded the highest burden in 2021, which is almost 300 times higher than in Western Europe. Elevated rates of mortality, DALYs and YLDs were also evident in Sierra Leone, Chad, Niger, Mali, Nigeria, Burkina Faso, Central African Republic, Somalia and South Sudan in 2021 and projections for 2050. However, the high-income Asia Pacific region had the lowest incidence, DALYs and YLDs at 151.32 (109.63–203.68), 2.21 (1.72–2.86) and 0.87 (0.46–1.38) per 1 00 000 women, respectively. Australasia recorded the lowest maternal death count and YLLs attributed to maternal haemorrhage at 0.69 (0.50–0.90) and 0.56 (0.41–0.74) per 1 00 000 women, respectively. Conclusion While the global burden of maternal haemorrhage has declined over time, significant regional and national inequities persist. Even though the 2050 projections show improvement in the burden of maternal haemorrhage, there is also regional and national variation in the rate of decrease in maternal haemorrhage burden. Targeted, context-specific interventions are urgently needed to reduce maternal haemorrhage-related mortality and morbidity.
- Open Access
- 1 June 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Machine learning models for predicting postpartum convulsions using clinical indicators from PMA Ethiopia data
Postpartum convulsions, defined as seizure episodes occurring after childbirth during the postpartum period, remain a major cause of maternal morbidity and mortality in Ethiopia. This study aimed to develop and validate machine learning models to predict postpartum convulsions using clinical indicators from performance monitoring for action (PMA) Ethiopia data set. Eight machine learning algorithms were developed and evaluated. Recursive Feature Elimination (RFE) approach was used for feature selection, and class imbalance was addressed using up-sampling techniques. The data were preprocessed and split into training (70%) and testing (30%) sets. Model performance was assessed using accuracy, sensitivity, specificity, and the area under the receiver operating characteristic curve (AUC). Model interpretability was examined using Shapley additive explanations (SHAP). The neural network model achieved the best predictive performance (AUC = 0.868), followed by support vector machine (AUC = 0.833) and Random forest (AUC = 0.822). SHAP analysis identified migraine, convulsion, and abdominal pain during pregnancy as the most influential predictors, followed by timing of ANC visits, blood pressure, and urine testing, and lack of treatment for pregnancy-related complications. Machine learning models, particularly Neural Networks, showed promising performance in predicting postpartum convulsions using routinely collected clinical data. The use of explainable artificial intelligence may help identify women at higher risk and support timely clinical decision-making, potentially contributing to reduced maternal complications in low-resource settings.
- 1 June 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessMachine learning models for predicting postpartum convulsions using clinical indicators from PMA Ethiopia data
Postpartum convulsions, defined as seizure episodes occurring after childbirth during the postpartum period, remain a major cause of maternal morbidity and mortality in Ethiopia. This study aimed to develop and validate machine learning models to predict postpartum convulsions using clinical indicators from performance monitoring for action (PMA) Ethiopia data set. Eight machine learning algorithms were developed and evaluated. Recursive Feature Elimination (RFE) approach was used for feature selection, and class imbalance was addressed using up-sampling techniques. The data were preprocessed and split into training (70%) and testing (30%) sets. Model performance was assessed using accuracy, sensitivity, specificity, and the area under the receiver operating characteristic curve (AUC). Model interpretability was examined using Shapley additive explanations (SHAP). The neural network model achieved the best predictive performance (AUC = 0.868), followed by support vector machine (AUC = 0.833) and Random forest (AUC = 0.822). SHAP analysis identified migraine, convulsion, and abdominal pain during pregnancy as the most influential predictors, followed by timing of ANC visits, blood pressure, and urine testing, and lack of treatment for pregnancy-related complications. Machine learning models, particularly Neural Networks, showed promising performance in predicting postpartum convulsions using routinely collected clinical data. The use of explainable artificial intelligence may help identify women at higher risk and support timely clinical decision-making, potentially contributing to reduced maternal complications in low-resource settings.
- Open Access
- 2 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Complementary feeding practices and associated factors among mothers of children aged 6–23 months in Debre Berhan town, Ethiopia
Appropriate nutrition during the first 1,000 days from pregnancy to a child’s second birthday is a critical window for optimal growth, cognitive development, and long-term health, with proper complementary feeding practices playing a pivotal role. Despite this, evidence on the magnitude of appropriate complementary feeding practices and their associated factors remains limited at the local level in Ethiopia. Therefore, this study assessed the Complementary Feeding Practices and Associated Factors among Mothers of Children Aged 6–23 Months in Debre Berhan Town, Ethiopia, in 2021. A community-based cross-sectional study was conducted from July 1 to August 30, 2021, using a cluster sampling technique in four randomly selected kebeles, including all eligible mothers. Data were collected using a structured interviewer-administered questionnaire, and appropriate complementary feeding practice was assessed based on WHO-recommended indicators. Data were entered into EpiData version 3.1 and analyzed using SPSS version 25. Multivariable logistic regression was used to identify factors associated with appropriate complementary feeding practice at p < 0.05. The prevalence of appropriate complementary feeding practice was 43.7%, and factors significantly associated included being a housewife (AOR = 2.53; 95% CI: 1.05–6.08), attending postnatal care (AOR = 3.18; 95% CI: 2.03–4.97), institutional delivery (AOR = 2.14; 95% CI: 1.11–4.14), and child vaccination (AOR = 1.89; 95% CI: 1.15–3.12). The level of appropriate complementary feeding practice in Debre Berhan Town (43.7%) remains suboptimal compared with WHO recommendations for children aged 6–23 months. Postnatal care attendance, being a housewife, institutional delivery, and child vaccination were significantly associated with appropriate complementary feeding practice. Strengthening postnatal counseling and integrating appropriate infant and young child feeding messages into routine vaccination services may help improve complementary feeding practices.
- 2 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessComplementary feeding practices and associated factors among mothers of children aged 6–23 months in Debre Berhan town, Ethiopia
Appropriate nutrition during the first 1,000 days from pregnancy to a child’s second birthday is a critical window for optimal growth, cognitive development, and long-term health, with proper complementary feeding practices playing a pivotal role. Despite this, evidence on the magnitude of appropriate complementary feeding practices and their associated factors remains limited at the local level in Ethiopia. Therefore, this study assessed the Complementary Feeding Practices and Associated Factors among Mothers of Children Aged 6–23 Months in Debre Berhan Town, Ethiopia, in 2021. A community-based cross-sectional study was conducted from July 1 to August 30, 2021, using a cluster sampling technique in four randomly selected kebeles, including all eligible mothers. Data were collected using a structured interviewer-administered questionnaire, and appropriate complementary feeding practice was assessed based on WHO-recommended indicators. Data were entered into EpiData version 3.1 and analyzed using SPSS version 25. Multivariable logistic regression was used to identify factors associated with appropriate complementary feeding practice at p < 0.05. The prevalence of appropriate complementary feeding practice was 43.7%, and factors significantly associated included being a housewife (AOR = 2.53; 95% CI: 1.05–6.08), attending postnatal care (AOR = 3.18; 95% CI: 2.03–4.97), institutional delivery (AOR = 2.14; 95% CI: 1.11–4.14), and child vaccination (AOR = 1.89; 95% CI: 1.15–3.12). The level of appropriate complementary feeding practice in Debre Berhan Town (43.7%) remains suboptimal compared with WHO recommendations for children aged 6–23 months. Postnatal care attendance, being a housewife, institutional delivery, and child vaccination were significantly associated with appropriate complementary feeding practice. Strengthening postnatal counseling and integrating appropriate infant and young child feeding messages into routine vaccination services may help improve complementary feeding practices.
- Open Access
- 18 March 2026
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (7) , 6654-6670
Survival Patterns of Patients with Ovarian Cancer in Africa: Systematic Review and Meta-analysis
Background: Ovarian cancer is among the most fatal gynecologic malignancies worldwide, with marked regional disparities in survival outcomes. In Africa, limited comprehensive data exist on survival rates, yet available evidence highlights late-stage diagnosis, restricted access to specialized oncology services, and inequities in treatment availability as key contributors to poor prognosis. Understanding these survival trends is critical not only for clinical awareness, but also for informing health system planning and guiding policy decisions aimed at improving cancer care infrastructure, resource allocation, and patient outcomes across the continent. This meta-analysis synthesizes current data to estimate 1-, 2-, 3-, 5-, and 7-year survival rates for patients with ovarian cancer in Africa, providing an essential benchmark for policymakers and healthcare providers to address gaps and disparities compared with global survival patterns. Materials and Methods: A systematic review of cohort studies was conducted from 1 to 29 February 2025, by using PubMed, Hinari, EMBASE, Google Scholar, and Web of Science. Methodological quality was assessed using the Newcastle–Ottawa 2016 Critical Appraisal Checklist. Publication bias was evaluated using funnel plots and Egger’s test, and heterogeneity was assessed with the I -squared test. Data were analyzed with Stata 11. Results: A total of 38 articles, including 7339 participants from African countries, were included in this review. Using a random-effects model, the pooled survival rates were estimated as follows: the 1-year survival rate was 71.41% (95% CI 63.71–79.11%); the 2-year survival rate was 69.08% (95% CI 57.31–80.85%); the 3-year survival rate was 61.49% (95% CI 45.19–77.80%); the 5-year survival rate was 61.73% (95% CI 52.72–70.74%); and the 7-year survival rate was 53.74% (95% CI 34.24–73.25%). Conclusions: This meta-analysis provides a broad overview of ovarian cancer survival rates in Africa, showing variation across timepoints and geographic regions. While the estimated survival rates are encouraging, they remain lower than those reported globally, highlighting ongoing challenges related to late diagnosis, limited treatment access, and healthcare disparities. Policymakers should prioritize raising awareness of cancer symptoms, enhancing early diagnosis through effective referral systems, investing in workforce capacity for specialized surgery and oncology care, and ensuring equitable access to quality cancer services. Further research and context-specific policy measures are essential to support sustainable improvements and the standardized International Federation of Gynaecology and Obstetrics (FIGO) staging system and World Health Organization (WHO) guidelines protocol in survival outcomes across the continent.
- 18 March 2026
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (7) , 6654-6670
Open AccessSurvival Patterns of Patients with Ovarian Cancer in Africa: Systematic Review and Meta-analysis
Background: Ovarian cancer is among the most fatal gynecologic malignancies worldwide, with marked regional disparities in survival outcomes. In Africa, limited comprehensive data exist on survival rates, yet available evidence highlights late-stage diagnosis, restricted access to specialized oncology services, and inequities in treatment availability as key contributors to poor prognosis. Understanding these survival trends is critical not only for clinical awareness, but also for informing health system planning and guiding policy decisions aimed at improving cancer care infrastructure, resource allocation, and patient outcomes across the continent. This meta-analysis synthesizes current data to estimate 1-, 2-, 3-, 5-, and 7-year survival rates for patients with ovarian cancer in Africa, providing an essential benchmark for policymakers and healthcare providers to address gaps and disparities compared with global survival patterns. Materials and Methods: A systematic review of cohort studies was conducted from 1 to 29 February 2025, by using PubMed, Hinari, EMBASE, Google Scholar, and Web of Science. Methodological quality was assessed using the Newcastle–Ottawa 2016 Critical Appraisal Checklist. Publication bias was evaluated using funnel plots and Egger’s test, and heterogeneity was assessed with the I -squared test. Data were analyzed with Stata 11. Results: A total of 38 articles, including 7339 participants from African countries, were included in this review. Using a random-effects model, the pooled survival rates were estimated as follows: the 1-year survival rate was 71.41% (95% CI 63.71–79.11%); the 2-year survival rate was 69.08% (95% CI 57.31–80.85%); the 3-year survival rate was 61.49% (95% CI 45.19–77.80%); the 5-year survival rate was 61.73% (95% CI 52.72–70.74%); and the 7-year survival rate was 53.74% (95% CI 34.24–73.25%). Conclusions: This meta-analysis provides a broad overview of ovarian cancer survival rates in Africa, showing variation across timepoints and geographic regions. While the estimated survival rates are encouraging, they remain lower than those reported globally, highlighting ongoing challenges related to late diagnosis, limited treatment access, and healthcare disparities. Policymakers should prioritize raising awareness of cancer symptoms, enhancing early diagnosis through effective referral systems, investing in workforce capacity for specialized surgery and oncology care, and ensuring equitable access to quality cancer services. Further research and context-specific policy measures are essential to support sustainable improvements and the standardized International Federation of Gynaecology and Obstetrics (FIGO) staging system and World Health Organization (WHO) guidelines protocol in survival outcomes across the continent.
- Open Access
Development and validation of a risk prediction model for preterm premature rupture of membranes: a cross-sectional study at North Wollo Zone governmental hospitals, Northern Ethiopia
Objectives: To develop and validate a risk prediction model for preterm premature rupture of membranes (PPROM) to enable early identification of at-risk women and support clinical decision-making in North Wollo Zone, Ethiopia. Design: A hospital-based retrospective cross-sectional study. Setting: Six public hospitals in the North Wollo Zone, Northern Ethiopia. Participants: A total of 1098 pregnant women were included in the study using systematic random sampling. Primary outcome measures: Occurrence of PPROM. Methods: Data were collected between 20 November 2023 and 20 March 2024, using structured interviews and medical record reviews. A risk prediction model was developed using Least Absolute Shrinkage and Selection Operator and logistic regression. Model performance was assessed through area under the curve (AUC), calibration plots and the Hosmer-Lemeshow test. Internal validation was conducted via bootstrap resampling. A simplified risk score was created to categorise women into high-risk and low-risk groups, and its clinical utility was evaluated using decision curve analysis. Results: Among the 1098 participants (100% response rate), the mean age was 21.54 years (IQR: 18–26), with 57.2% aged 20–34 years. The prevalence of PPROM was 10.75% (95% CI 9.01% to 12.77%). Seven significant predictors were identified: maternal age <20 years, urinary tract infection, anaemia, history of PROM, pregnancy-induced hypertension, short birth interval and polyhydramnios. The model demonstrated good discrimination (AUC=0.873; bias-corrected AUC=0.87). A simplified risk score (range 3–13) using a cut-off of ≥6.5 classified women into low-risk and high-risk groups, with PPROM incidence rates of 4.76% and 38.7%, respectively. Decision curve analysis showed good clinical utility, and a nomogram was developed for individualised risk assessment. Conclusions: PPROM remains a significant obstetric complication in the study area. The validated risk prediction model showed moderate to good performance and can be used to support early screening and risk-based management in antenatal care (ANC). Integrating the tool into routine ANC services, along with health education and management of modifiable risk factors, may help reduce PPROM-related adverse outcomes. Further external validation is recommended.
Open AccessDevelopment and validation of a risk prediction model for preterm premature rupture of membranes: a cross-sectional study at North Wollo Zone governmental hospitals, Northern Ethiopia
Objectives: To develop and validate a risk prediction model for preterm premature rupture of membranes (PPROM) to enable early identification of at-risk women and support clinical decision-making in North Wollo Zone, Ethiopia. Design: A hospital-based retrospective cross-sectional study. Setting: Six public hospitals in the North Wollo Zone, Northern Ethiopia. Participants: A total of 1098 pregnant women were included in the study using systematic random sampling. Primary outcome measures: Occurrence of PPROM. Methods: Data were collected between 20 November 2023 and 20 March 2024, using structured interviews and medical record reviews. A risk prediction model was developed using Least Absolute Shrinkage and Selection Operator and logistic regression. Model performance was assessed through area under the curve (AUC), calibration plots and the Hosmer-Lemeshow test. Internal validation was conducted via bootstrap resampling. A simplified risk score was created to categorise women into high-risk and low-risk groups, and its clinical utility was evaluated using decision curve analysis. Results: Among the 1098 participants (100% response rate), the mean age was 21.54 years (IQR: 18–26), with 57.2% aged 20–34 years. The prevalence of PPROM was 10.75% (95% CI 9.01% to 12.77%). Seven significant predictors were identified: maternal age <20 years, urinary tract infection, anaemia, history of PROM, pregnancy-induced hypertension, short birth interval and polyhydramnios. The model demonstrated good discrimination (AUC=0.873; bias-corrected AUC=0.87). A simplified risk score (range 3–13) using a cut-off of ≥6.5 classified women into low-risk and high-risk groups, with PPROM incidence rates of 4.76% and 38.7%, respectively. Decision curve analysis showed good clinical utility, and a nomogram was developed for individualised risk assessment. Conclusions: PPROM remains a significant obstetric complication in the study area. The validated risk prediction model showed moderate to good performance and can be used to support early screening and risk-based management in antenatal care (ANC). Integrating the tool into routine ANC services, along with health education and management of modifiable risk factors, may help reduce PPROM-related adverse outcomes. Further external validation is recommended.
- Open Access
- 3 April 2025
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1459613
Predictors of survival among breast cancer patients in Ethiopia: a systematic review and meta-analysis
Introduction: Breast cancer remains a significant public health issue, with delayed medical attention often leading to advanced stages and poorer survival rates. In East Africa, evidence on the prevalence and factors contributing to the delayed presentation of breast cancer is limited. As a result, this study aims to assess the pooled prevalence of delayed breast cancer presentation and identify contributing factors in East Africa.Methods: We conducted a systematic review of observational studies from East Africa using PubMed, Google Scholar, Embase, Cochrane Library, Hinari, and Mednar databases. The Newcastle Ottawa 2016 Critical Appraisal Checklist assessed methodological quality. Publication bias was evaluated using a funnel plot and Egger’s test, and heterogeneity was examined with the I-squared test. Data were extracted with Microsoft Excel and analyzed using Stata 11.Results: The pooled prevalence of delayed presentation among breast cancer patients in East Africa was 61.85% (95% confidence interval, 48.83%–74.88%). Significant factors contributing to delayed presentation included visiting traditional healers (adjusted odds ratio, 3.52; 95% CI, 1.43–5.59), low educational levels (adjusted odds ratio, 3.61; 95% CI, 2.39–4.82), age > 40 years (adjusted odds ratio, 1.87; 1.03, 2.71), absence of breast pain (adjusted odds ratio, 2.42; 1.09, 3.74), distance >5 km away from home to health institution (adjusted odds ratio, 2.89; 1.54, 4.24), and rural residence (adjusted odds ratio, 3.33; 95% CI, 2.16–4.49).Conclusion: This meta-analysis’ findings demonstrated that over half of breast cancer patients in East Africa delayed detection. Significant factors associated with delayed presentation include age over 40 years, illiteracy, rural residence, use of traditional healers, distance >5 km from a health facility, and absence of breast pain. Healthcare stakeholders and policymakers must be focused on raising awareness and educating people to encourage early detection and prompt therapy.
- 3 April 2025
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1459613
Open AccessPredictors of survival among breast cancer patients in Ethiopia: a systematic review and meta-analysis
Introduction: Breast cancer remains a significant public health issue, with delayed medical attention often leading to advanced stages and poorer survival rates. In East Africa, evidence on the prevalence and factors contributing to the delayed presentation of breast cancer is limited. As a result, this study aims to assess the pooled prevalence of delayed breast cancer presentation and identify contributing factors in East Africa.Methods: We conducted a systematic review of observational studies from East Africa using PubMed, Google Scholar, Embase, Cochrane Library, Hinari, and Mednar databases. The Newcastle Ottawa 2016 Critical Appraisal Checklist assessed methodological quality. Publication bias was evaluated using a funnel plot and Egger’s test, and heterogeneity was examined with the I-squared test. Data were extracted with Microsoft Excel and analyzed using Stata 11.Results: The pooled prevalence of delayed presentation among breast cancer patients in East Africa was 61.85% (95% confidence interval, 48.83%–74.88%). Significant factors contributing to delayed presentation included visiting traditional healers (adjusted odds ratio, 3.52; 95% CI, 1.43–5.59), low educational levels (adjusted odds ratio, 3.61; 95% CI, 2.39–4.82), age > 40 years (adjusted odds ratio, 1.87; 1.03, 2.71), absence of breast pain (adjusted odds ratio, 2.42; 1.09, 3.74), distance >5 km away from home to health institution (adjusted odds ratio, 2.89; 1.54, 4.24), and rural residence (adjusted odds ratio, 3.33; 95% CI, 2.16–4.49).Conclusion: This meta-analysis’ findings demonstrated that over half of breast cancer patients in East Africa delayed detection. Significant factors associated with delayed presentation include age over 40 years, illiteracy, rural residence, use of traditional healers, distance >5 km from a health facility, and absence of breast pain. Healthcare stakeholders and policymakers must be focused on raising awareness and educating people to encourage early detection and prompt therapy.